Cornerstone Therapeutics (CRTX) +20% AH to $6.55 after disclosing Italy's Chiesi Therapeutics,...

|About: Cornerstone Therapeutics Inc. (CRTX)|By:, SA News Editor

Cornerstone Therapeutics (CRTX) +20% AH to $6.55 after disclosing Italy's Chiesi Therapeutics, which already owns 65% of Cornerstone, delivered a letter yesterday offering to buy the rest of it for $6.40-$6.70/share in cash. (13D)